Agenda

BioSpectrum Asia (BSA) is unveiling "BioSpectrum Asia Symposium, 2023" to explore and indulge in novel facets of Bioscience, Biopharma, Biotech, MedTech and Healthcare industries with a primary objective to foster and bolster Singapore's expertise across diverse biomedical domains. The Symposium aims to stimulate Singapore's Bioscience ecosystem by convening elite bioscience entrepreneurs and industry advisers to engage in a day of substantive interactive sessions. Senior executives, business leaders, and experts will explore a plethora of topics through insightful presentations.

We are overwhelmed by the industry elite's involvement in Dec 2022 on the Occasion of BioSpectrum Asia Excellence Award 2022

The upcoming symposium is a gesture of gratitude and appreciation to Singapore's Bioscience community.

Ideal for Bioscience, Healthcare, Biotech Medtech, Clinical, Pharma, Biopharma, Healthtech, Therapeutic companies, Innovators & Entrepreneurs

Optimize Your Bioscience Endeavours in the Premier Industry Gathering

Date: 4 Dec  2023 | Time: 10 AM to 6 PM

9.00 - 10.00 AM

Registration
Welcome etiquette

10.00 - 10.15 AM

Opening Remarks

10.15 - 10.30 AM

Snapshot of Bioscience Entrepreneurship Ecosystem
Dr. Brendan Sieow, President, Biotech Connection Singapore

Session 1
10.30 - 11.00 AM

Iskandar Malaysia: Ecosystem for Bioscience Business Growth
Prakash Nagarajan, Vice President, Economics & Investment, Iskandar Regional Development Authority (IRDA), Malaysia

Session 2
11.00 - 11.30 AM

Why Asia is Yet to Produce a Groundbreaking Healthcare Innovation: Identifying Gaps in the systemic ecosystem
Chris Lee, Founder & CEO, VentureBlick, Singapore

Session 3
11.30 - 12.00 PM

Leveraging on market access in building a successful medtech Venture
Dr. Buzz Palmer, Co-Founder & CEO, MedTech Actuator, Singapore

12.00 - 12.45 PM

Panel Discussion
Striving Life Science Innovations Through Market Dynamics

  • Amkidit Afable, Corporate Strategy, Business Model Innovation, M&A, EY-Parthenon
  • Krishna Karnati, General Manager Commercial, Genomic Medicine APAC, Cytiva
  • Cairan He, Director of Investor Relations & Partnerships, VentureBlick, Singapore

12.45 - 1.45 PM : LUNCH BREAK

Session 4
1.45 - 2.05 PM

Synthetic Biology (SynBio): The Manufacturing Paradigm of the Future
Kostas Vavitsas, Head of Innovation and Enterprise, Consortium Manager at SINERGY, A*STAR, Singapore

Session 5
2.05 - 2.35 PM

Accelerating Healthcare Innovation Through Collaboration
Dr. Sharon Chan, VP JLABS Asia Pacific, Accelerating Healthcare Innovation, Entrepreneurial Leader & Mentor, Singapore

Session 6
2.35 - 3.05 PM

Current State of VC and PE Deal Activities in Digital Health
Arnaud Bauer, Head of Healthcare Services, L.E.K. Consulting, Digital Health and Healthcare M&A for SEA, Singapore

3.05 - 3.50 PM

FireSide Chat
"Bridging the innovation gap: From idea to market"?

  • Thye Chee Yung, Associate Director, Hello Tomorrow Asia Pacific, Singapore
  • Dr. Ang Hui Ying, Associate Director, Technology Transfer and Innovation (TTI), NUS Enterprise, Singapore
  • Dr. Wong Han Teng, Advisor, Biotech Connection Singapore

3.50 PM - 4.15 PM : Tea Break

4.15 - 5.30 PM

Plenary Session; Q&A Session
Navigating Investor and Stakeholder Opportunities in the Bioscience Enterprise Landscape

  • Dr. Dario Heymann, Founding Member & CRO, Galen Growth, Singapore
  • Sowmya Srinath, Director Healthcare & Life Sciences, Frost & Sullivan, Singapore
  • Yue (Shelby) Zhang, Investment Director, Vertex Growth, Singapore

   Moderator:

  • Andrew Wu, Co-Founder & CEO, Mesh Bio, Singapore

5.30 PM : Closing Remarks